The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Journal of Urology

• Publication date

  1978-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(17)57526-6PMID 650752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The surgical management of bladder carcinoma.

  1976cited by this paper
• The surgical management of bladder carcinoma.

  1976cited by this paper
• Histopathology and classification of urinary bladder carcinoma.

  1976cited by this paper
• Radiotherapy: definitive, integrated and palliative therapy.

  1976cited by this paper
• Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ.

  1976cited by this paper
• Superficial bladder tumor. Aspects of clinical progression.

  1974cited by this paper
• Strategy of surgical management of bladder cancer.

  1973cited by this paper
• Papilloma of the urinary bladder

  1970cited by this paper
• Introduction to the clinical use of isotopes in renal disease.

  1969cited by this paper
• The forces of mortality in bladder carcinoma.

  1969cited by this paper
• The Bristol Bladder Tumour Registry.

  1969cited by this paper
• The treatment of bladder tumors.

  1969cited by this paper
• Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years.

  1965cited by this paper
• REPORT OF A FOLLOW-UP OF PAPILLARY TUMOURS OF THE BLADDER.

  1964cited by this paper
• A study of 2678 patients with initial carcinoma of the bladder. I. Survival rates.

  1956cited by this paper

• Adenomatous Polyposis Coli (APC) Promoter Gene Methylation in Urine-Derived DNA: A Non-invasive Biomarker for Early Bladder Cancer Detection and Tumor Aggressiveness

  2024cites this paper
• Neoplasms of the Urinary Bladder

  2020cites this paper
• Effect of delayed radical cystectomy for invasive bladder tumors on lymph node positivity, cancer-specific survival and total survival

  2018cites this paper
• THE MORPHOLOGIC OVERLAP BETWEEN BENIGN AND MALIGNANT IN THE URINARY BLADDER: DIAGNOSTIC DILEMMAS

  2013cites this paper
• Tumors of the Urinary Bladder

  2013cites this paper
• Grading of Bladder Cancer

  2012cites this paper
• Histologic grading of urothelial carcinoma: a reappraisal.

  2012cites this paper
• Wertigkeit von CEA und CA 19-9 in verschiedenen Stadien des Harnblasenkarzinoms: serologische und immunhistochemische Ergebnisse

  2011cites this paper
• The Lower Urinary Tract and Male Genital System

  2010cites this paper
• Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up.

  2010cites this paper
• Superficial bladder cancer metastatic to the lungs: two case reports and review of the literature.

  2009cites this paper
• Tumours in Iceland. 6. Tumours of the urinary bladder, ureter and urethra. A histological classification and some epidemiological and environmental factors.

  2009cites this paper
• Case report Superficial Bladder Cancer Metastatic to the Lungs: Two Case Reports and Review of the Literature

  2008cites this paper
• Experiencia de 5 años en el manejo del carcinoma vesical superficial de células transicionales con BCG en el Centro Médico Nacional “20 de Noviembre” ISSSTE

  2008cites this paper
• The Value of Second Look Transurethral Resection in the Evaluation and Management of Patients with Bladder Tumors

  2008cites this paper
• Clinical Condition: Follow-up Imaging of Bladder Carcinoma Variant 1: Superficial TCC-no invasion or risk factors.

  2007cites this paper
• Responseof Nude Mouse-grownHumanUrothelialCancerto c / s-Diammine-dichloroplatinum ( ll ) , Diammine [ 1 , 1-cyclobutanedicarboxylato ( 2-)-O , O '-platinum ] , and MitoguazoneDihydrochloride 1 ' 2

  2006cites this paper
• Expectant treatment of small, recurrent, low-grade, noninvasive tumors of the urinary bladder.

  2006cites this paper
• La influencia de la "resección transuretral diferenciada" en la recurrencia y progresión en cáncer vesical superficial

  2006cites this paper
• The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification

  2005cites this paper
• Association of low CYP 3 A activity with p 53 mutation and CYP 2 D 6 activity with Rb mutation in human bladder cancer

  2005cites this paper
• Prognostic factors in superficial bladder cancer

  2005cites this paper
• Invasiveness of transformed bladder epithelial cells

  2004cites this paper
• Karyometry in recurrent superficial transitional cell tumors of the bladder

  2004cites this paper
• A follow-up study of urinary bladder patients tested for tumour-related lymphocyte-mediated cytotoxicity

  2004cites this paper
• TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.

  2004cites this paper
• Intravesical administration of tumor-associated monoclonal antibody AUA1 in transitional cell carcinoma of the bladder: a study of biodistribution

  2004cites this paper
• A phase I study of intravesical suramin for the treatment of superficial transitional cell carcinoma of the bladder.

  2003cites this paper
• Fatores de risco em carcinomas de células transicionais da bexiga: risk factors

  2002cites this paper
• Repeated Transurethral Resection of Recurrent Superficial Bladder Tumors: Does it Affect the Spread and Stage of the Tumor?

  2002cites this paper
• Local immunostimulation induced by intravesical administration of autologous interferon‐gamma‐activated macrophages in patients with superficial bladder cancer

  2002cites this paper
• Klinische Diagnostik und Therapie des oberflächlichen Harnblasenkarzinoms

  2002influential citation
• Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression.

  2002cites this paper
• Role of ultrasonography and urinary cytology in diagnosing recurrence of superficial urinary bladder cancer compared to cystoscopy.

  2001cites this paper
• The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder.

  2001cites this paper
• Intravesical Chemotherapy in the Treatment of Superficial Bladder Cancer

  2001cites this paper
• Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion

  2001cites this paper
• Blasencarcinome und Carcinome des Übergangsepithels

  2001cites this paper
• The use of hydrogen peroxide to enhance the efficacy of doxorubicin hydrochloride in a murine bladder tumor cell line.

  2001cites this paper
• Bacillus Calmette-Guerin. Is monthly maintenance an option for transitional cell carcinoma of the bladder?

  2001cites this paper
• Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.

  2000cites this paper
• Bacillus Calmette-Guerin. Is monthly maintenance an option for transitional cell carcinoma of the bladder?

  2000cites this paper
• Prevention of Urinary Bladder Cancer: The Interface Between Experimental and Human Studies.

  2000cites this paper
• Vascular endothelial growth factor and its correlation with superficial bladder cancer recurrence rates and stage progression.

  2000cites this paper
• Papillary urothelial neoplasms of low malignant potential

  1999cites this paper
• Bladder. Risk and prognostic factors--a pathologist's perspective.

  1999cites this paper
• Expression of immunohistochemical markers (PCNA, Ki-67, 486p and p53) on paraffin sections and their relation to the recurrence rate of superficial bladder tumors.

  1999cites this paper
• CARCINOMA TRANSICIONAL DE VEJIGA. Quimioprofilaxis endovesical TRANSITIONAL CELL BLADDER CARCINOMA. Intravesical chemotherapy

  1999cites this paper
• Computed Tomography of the Bladder

  1998cites this paper
• Review article Alterations in cyclin D1, p53, and the cell cycle related elements Implications for distinct genetic pathways of urinary bladder carcinogenesis.

  1998cites this paper
• Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder.

  1998cites this paper
• Pathology of Bladder Cancer

  1998cites this paper
• Determination of interferon-alpha receptors in urothelial cancer and in normal urothelium.

  1997cites this paper
• Intravesical immunoprophylaxis in recurrent superficial bladder cancer (Stage T1): multicenter trial comparing bacille Calmette-Guérin and interferon-alpha.

  1997cites this paper
• Angiogenesis inhibitor TNP-470 suppresses tumorigenesis in rat urinary bladder.

  1997cites this paper
• Significance of p53 overexpression in urinary bladder transitional cell carcinoma in situ before and after bacillus Calmette-Guérin treatment.

  1997cites this paper
• Der Wert immunhistochemischer Marker (PCNA, K-67, 486 p und p53) in der Abschätzung des Rezidivrisikos oberflächlicher Blasenkarzinome

  1997cites this paper
• Association of low CYP3A activity with p53 mutation and CYP2D6 activity with Rb mutation in human bladder cancer.

  1996cites this paper
• Prognostic factors for survival in patients with transitional cell carcinoma of the bladder: evaluation by histopathologic grade, pathologic stage and flow-cytometric analysis.

  1996cites this paper
• Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell carcinoma of the bladder.

  1996cites this paper
• Low dose Pasteur bacillus Calmette-Guerin regimen in stage T1, grade 3 bladder cancer therapy.

  1996cites this paper
• Prognostic evaluation of morphonuclear parameters in superficial and invasive bladder cancer.

  1995cites this paper
• p53 gene mutation in recurrent superficial bladder cancer.

  1995cites this paper
• Espressione di oncogeni di proliferazione e morte cellulare nel carcinoma superficiale della vescica: Expression of oncogenes in relation to cell proliferation and death in superficial bladder carcinoma

  1995cites this paper
• The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years.

  1995cites this paper
• Does hyperbaric oxygen have a cancer-causing or -promoting effect? A review of the pertinent literature.

  1994cites this paper
• Results of transurethral resection and intravesical doxorubicin prophylaxis in patients with T1G3 bladder cancer.

  1994cites this paper
• Altered patterns of MDM2 and TP53 expression in human bladder cancer.

  1994cites this paper
• Urinary bladder cancer: mechanisms of development and progression.

  1994cites this paper
• Same day diagnostic service for new cases of haematuria--a district general hospital experience.

  1994cites this paper
• Cystoscopy in bladder cancer

  1994cites this paper
• Superficial bladder carcinoma

  1993cites this paper
• Long-term results of intravesical therapy for superficial bladder cancer.

  1992cites this paper
• Cytologic and histologic features of superficial bladder cancer.

  1992cites this paper
• Partial cystectomy.

  1992cites this paper
• Natural history of early bladder cancer

  1992cites this paper
• Natural history of superficial bladder cancer. Prognostic features and long-term disease course.

  1992cites this paper
• Analysis by Step Sectioning of Early Invasive Bladder Cancer with Special Reference to G3·pT1 Disease

  1992cites this paper
• Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group.

  1992cites this paper
• Superficial bladder cancer.

  1992cites this paper
• Distribution of 486P 3/12 antigen, ABO(H) blood group antigen and T antigen in cystectomy specimens from patients with stage T2 transitional cell carcinoma of the bladder.

  1992cites this paper
• H-ras oncogene mutations in the urine of patients with bladder-tumors - description of a noninvasive method for the detection of neoplasia.

  1992cites this paper
• Molecular genetic alterations in superficial and locally advanced human bladder cancer.

  1991cites this paper
• Phase I‐II evaluation of intravesical novantrone (mitoxantrone) in superficial bladder cancer

  1991cites this paper
• Nuclear volume in transitional cell tumours. An assessment of its prognostic and biological impact.

  1991cites this paper
• Factors affecting survival in primary superficial bladder cancer.

  1990cites this paper
• Trattamento Profilattico Con Mitomycin-C Dei Tumori Uroteliali Superficiali Della Vescica

  1990cites this paper
• Current understanding of pathology of bladder cancer and attendant problems.

  1990cites this paper
• Urothelial grafts in mice.

  1990cites this paper
• Quantitative immunocytology in the management of patients with superficial bladder carcinoma. I. A marker to identify patients who do not require prophylaxis.

  1990cites this paper
• Risikofaktoren beim primären oberflächlichen Harnblasenkarzinom

  1990cites this paper
• Pathology of bladder cancer: assessment of prognostic variables and response to therapy.

  1990cites this paper
• Role of endoscopy in the diagnosis of cancer: a consensus statement prepared by a working party of the International Union against Cancer.

  1989cites this paper
• Limitations of flow cytometric DNA analysis for the diagnosis of bladder cancer

  1989cites this paper
• Urinary cytology in the detection of bladder tumours. Influence of concomitant urothelial atypia.

  1989cites this paper
• Split-course radiotherapy for urinary bladder cancer.

  1989cites this paper
• Benign and low-grade papillary lesions of the urinary bladder: a review of the papilloma-papillary carcinoma controversy, and a report of five typical papillomas.

  1989cites this paper
• Diagnosis and management of superficial bladder cancer.

  1989cites this paper
• Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis.

  1988cites this paper
• Sucralfate inhibition of tumor cell implantation in the murine urinary bladder.

  1988cites this paper